Our response to major trial suggesting that combining drugs could extend breast cancer survival

The trial tested the benefit of adding palbociclib to fulvestrant in 521 women with advanced, hormone positive, HER2 negative breast cancer. While...

22 October 2018

Theresa May pledges to increase early detection of cancer

Responding to Theresa May’s aim to increase early detection of cancer as outlined at the Conservative Party Conference on Wednesday 3 October,...

4 October 2018

Future projections for number of UK women dying from breast cancer

Responding to new projections about the number of women dying from breast cancer in the UK, Samia al Qadhi, Chief Executive of Breast Cancer Care,...

28 September 2018

Our response to figures showing almost 4,000 missed breast cancer screening invitations in Scotland in 2016

Mia Rosenblatt, Assistant Director of Policy and Campaigns at Breast Cancer Now, said: It’s incredibly worrying that, despite a recent review,...

24 September 2018

Release of NHS England Cancer Waiting Times for July show targets being missed

Responding to NHS England’s Cancer Waiting Times for July 2018, Gunes Kalkan, Head of Evidence, Policy and Campaigns at Breast Cancer Care,...

13 September 2018

Breast screening errors in Scotland revealed

Responding to an announcement from Jeane Freeman MSP, Health Secretary, revealing that 1,761 women aged over 71 in Scotland were not invited for...

13 September 2018

New online tool could "revolutionise" decisions on hormone therapy

Responding to a new online tool that could better predict the long-term risk of oestrogen receptor positive breast cancer returning and the need for...

24 August 2018

A further rejection by NICE of Perjeta for use after sugery

Responding to the updated draft guidance from NICE to not recommend Perjeta (pertuzumab) for routine NHS use after surgery for early HER2-positive...

17 August 2018

Response to possibility of further breast screening invitation issues

Responding to news that health officials are investigating concerns that adults who should have been invited for breast and bowel cancer screening...

11 August 2018